» Articles » PMID: 37988390

A Cohort Study on the Biochemical and Haematological Parameters of Italian Blood Donors As Possible Risk Factors of COVID-19 Infection and Severe Disease in the Pre- and Post-Omicron Period

Overview
Journal PLoS One
Date 2023 Nov 21
PMID 37988390
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the association between biochemical and blood parameters collected before the pandemic in a large cohort of Italian blood donors with the risk of infection and severe disease. We also focused on the differences between the pre- and post-Omicron spread in Italy (i.e., pre- and post-January 01, 2022) on the observed associations. We conducted an observational cohort study on 13750 blood donors was conducted using data archived up to 5 years before the pandemic. A t-test or chi-squared test was used to compare differences between groups. Hazard ratios with 95% confidence intervals for SARS-CoV-2 infection and severe disease were estimated using Cox proportional hazards models. Subgroup analyses stratified by sex, age and epidemic phase of first infection (pre- and post-Omicron spread) were examined. We confirmed a protective effect of groups B and O, while groups A and AB had a higher likelihood of infection and severe disease. However, these associations were only significant in the pre-Omicron period. We found an opposite behavior after Omicron spread, with the O phenotype having a higher probability of infection. When stratified by variant, A antigen appeared to protect against Omicron infection, whereas it was associated with an increased risk of infection by earlier variants. We were able to stratify for the SARS CoV-2 dominant variant, which revealed a causal association between blood group and probability of infection, as evidenced by the strong effect modification observed between the pre- and post-Omicron spread. The mechanism by which group A acts on the probability of infection should consider this strong effect modification.

Citing Articles

Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity.

Ferous S, Siafakas N, Boufidou F, Patrinos G, Tsakris A, Anastassopoulou C J Pers Med. 2024; 14(4).

PMID: 38672973 PMC: 11051264. DOI: 10.3390/jpm14040346.

References
1.
Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A . Is asthma protective against COVID-19?. Allergy. 2020; 76(3):866-868. PMC: 7300712. DOI: 10.1111/all.14426. View

2.
Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X . Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin Infect Dis. 2020; 73(2):328-331. PMC: 7454371. DOI: 10.1093/cid/ciaa1150. View

3.
Golding J, Northstone K, Miller L, Davey Smith G, Pembrey M . Differences between blood donors and a population sample: implications for case-control studies. Int J Epidemiol. 2013; 42(4):1145-56. PMC: 3781001. DOI: 10.1093/ije/dyt095. View

4.
Matzhold E, Berghold A, Bemelmans M, Banfi C, Stelzl E, Kessler H . Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2. Transfusion. 2021; 61(9):2736-2745. PMC: 8447157. DOI: 10.1111/trf.16567. View

5.
Franchini M, Cruciani M, Mengoli C, Marano G, Candura F, Lopez N . ABO blood group and COVID-19: an updated systematic literature review and meta-analysis. Blood Transfus. 2021; 19(4):317-326. PMC: 8297670. DOI: 10.2450/2021.0049-21. View